|Other Names||Inositol-trisphosphate 3-kinase A, Inositol 1, 5-trisphosphate 3-kinase A, IP3 3-kinase A, IP3K A, InsP 3-kinase A, ITPKA|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP8166b was selected from the C-term region of human ITPKA . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
ITPKA regulates inositol phosphate metabolism by phosphorylation of second messenger inositol 1,4,5-trisphosphate to Ins(1,3,4,5)P4. The activity of the inositol 1,4,5-trisphosphate 3-kinase is responsible for regulating the levels of a large number of inositol polyphosphates that are important in cellular signaling. Both calcium/calmodulin and protein phosphorylation mechanisms control its activity. It is also a substrate for the cyclic AMP-dependent protein kinase, calcium/calmodulin- dependent protein kinase II, and protein kinase C in vitro. ITPKA and ITPKB are 68% identical in the C-terminus region.
Gonzalez, B., et al., Mol. Cell 15(5):689-701 (2004).Mishra, J., et al., Biophys. J. 83(3):1298-1316 (2002).Schell, M.J., et al., J. Biol. Chem. 276(40):37537-37546 (2001).Communi, D., et al., EMBO J. 16(8):1943-1952 (1997).Woodring, P.J., et al., J. Biol. Chem. 272(48):30447-30454 (1997).
If you have any additional inquiries please email technical services at firstname.lastname@example.org.